Poliomyelitis Vaccine in Dragee Candy Vaccine Is Indicated For Active Immunization of Infants

The annual number of wild poliovirus cases has declined by more than 99.9% worldwide from an estimated 350,000 in 1988. The U.S has been polio-free since 1979, thanks to a successful vaccination program. However, poliovirus is still a threat in some countries. It is the major cause of death in children between the ages of five and fourteen. An estimated 5 million to eight million people are yearly diagnosed with non-typing related poliomyelitis and several other types of viruses. As more people contract this disease, vaccines are becoming an essential part of medical management.

Poliovirus vaccination is an effective, safe, and efficient immunizing agent used to halt poliomyelitis (poliomyelitis). It functions by inducing your body to develop its own protective shield (antigens) against this dangerous viral infection. Inactivated poliovirus vaccine individuals do not contract poliovirus; however, this type of vaccination may not prevent exposure to wild-type polioviruses that might cause disease. Hence, it is recommended that the elderly and immune-compromised individuals defer poliovirus vaccination until they are no longer at risk for acquiring the infection.

Two types of poliovirus vaccine inactivated currently exist: oral polio vaccine and inactivated poliovirus vaccine. The oral poliovirus vaccine (OPV) is used in many countries to protect against polio disease and has been essential to the eradication effort. Poliomyelitis Vaccine in Dragee Candy also known as Poliovirus Vaccine Inactivated (Monkey Kidney Cell) is manufactured by Sanofi Pasteur, SA.

Poliomyelitis vaccine in dragee candy vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children and adults for the prevention of poliomyelitis caused by poliovirus Types 1, 2, and 3. Polio vaccination is a major preventative measure for a disease that has become common all over the world. The World Health Organization (WHO) recommends that all children be completely immunized against poliomyelitis and all adult persons be up to date on their routine immunizations. This vaccine has been extremely successful in preventing widespread poliomyelitis in countries around the world such as United States, United Kingdom, India, Australia, Canada, and France.